EXHIBIT 107.1

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Ampio Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type	Security Class Title	Fee Calculation Rule	Amount Registered(1)(2)	Proposed Maximum Offering Price Per Unit(3)	Maximum Aggregate Offering Price	Fee Rate	Amount of Registration Fee
Equity	Common Stock, par value $0.0001 per share	Rule 457(c) and Rule 457(h)	1,200,000	$0.205	$246,000	0.00011020	$27.11
					Total Offering Amount:		$27.11
					Total Fee Offsets:		-
					Net Fee Due:		$27.11

(1)            Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), the registration statement on Form S-8 shall also cover any additional shares of the common stock of Ampio Pharmaceuticals, Inc. (the “Registrant”) that become issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration that results in an increase in the number of the outstanding shares of the Registrant’s common stock.

(2)            As described in the Explanatory Note to this Registration Statement, represents 1,200,000 shares that were authorized for issuance under the Registrant’s 2023 Stock and Incentive Plan by approval of the Registrant’s stockholders on July 27, 2023.

(3)            Estimated solely for the purpose of calculating the registration fee and computed in accordance with Rule 457(c) and (h) under the Securities Act using the average of the high and low sale prices of the common stock on August 11, 2023, as reported on the NYSE American.